CLINICAL_TRIALS
trial_result
· 2009-07-08
Clinical Trial Update: Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy [Phase 3]
Summary
A Phase 3 trial comparing the combination of fenofibrate with 40 mg simvastatin versus 40 mg simvastatin alone has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Solvay Pharmaceuticals | Conditions: Cardiovascular Diseases | Phase 3 | Status: COMPLETED